 | Up a level |
Mazurek, Michal, Halperin, Jonathan L, Huisman, Menno V, Diener, Hans-Christoph, Dubner, Sergio J, Ma, Chang Sheng, Rothman, Kenneth J, Healey, Jeff S, Teutsch, Christine, Paquette, Miney et al (show 4 more authors)
(2020)
Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme.
EUROPACE, 22 (1).
pp. 47-57.
Mazurek, Michal, Shantsila, Eduard 
ORCID: 0000-0002-2429-6980, Lane, Deirdre A ORCID: 0000-0002-5604-9378, Wolff, Andreas, Proietti, Marco ORCID: 0000-0003-1452-2478 and Lip, Gregory YH ORCID: 0000-0002-7566-1626
(2017)
Guideline-Adherent Antithrombotic Treatment Improves Outcomes in Patients With Atrial Fibrillation: Insights From the Community-Based Darlington Atrial Fibrillation Registry.
MAYO CLINIC PROCEEDINGS, 92 (8).
pp. 1203-1213.
Gumprecht, Jakub, Szulik, Mariola, Domek, Magdalena, Mazurek, Michal, Shantsila, Alena ORCID: 0000-0002-0594-8576, Oxborough, David and Lip, Gregory YH ORCID: 0000-0002-7566-1626
(2019)
Novel Echocardiographic Biomarkers in the Management of Atrial Fibrillation.
CURRENT CARDIOVASCULAR IMAGING REPORTS, 12 (12).
Koziel, Monika, Mazurek, Michal, Teutsch, Christine, Diener, Hans-Christoph, Dubner, Sergio J, Halperin, Jonathan L, Ma, Chang-Sheng, Rothman, Kenneth J, Brandes, Axel, Paquette, Miney et al (show 6 more authors)
(2020)
Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up.
JOURNAL OF CLINICAL MEDICINE, 9 (6).
E1969-.